nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—BCHE—Alzheimer's disease	0.301	0.685	CbGaD
Drospirenone—BCHE—Rivastigmine—Alzheimer's disease	0.274	0.66	CbGbCtD
Drospirenone—BCHE—Galantamine—Alzheimer's disease	0.141	0.34	CbGbCtD
Drospirenone—PTGS2—Alzheimer's disease	0.139	0.315	CbGaD
Drospirenone—Infarction—Galantamine—Alzheimer's disease	0.00818	0.108	CcSEcCtD
Drospirenone—Cerebral infarction—Donepezil—Alzheimer's disease	0.0054	0.0712	CcSEcCtD
Drospirenone—Cerebral infarction—Memantine—Alzheimer's disease	0.0049	0.0646	CcSEcCtD
Drospirenone—Embolism venous—Memantine—Alzheimer's disease	0.00317	0.0417	CcSEcCtD
Drospirenone—Embolism—Memantine—Alzheimer's disease	0.00249	0.0328	CcSEcCtD
Drospirenone—Thrombosis—Rivastigmine—Alzheimer's disease	0.00221	0.0291	CcSEcCtD
Drospirenone—PGR—blood vessel—Alzheimer's disease	0.00194	0.113	CbGeAlD
Drospirenone—Breast pain—Rivastigmine—Alzheimer's disease	0.00179	0.0236	CcSEcCtD
Drospirenone—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00168	0.0222	CcSEcCtD
Drospirenone—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.0013	0.0172	CcSEcCtD
Drospirenone—Depression—Galantamine—Alzheimer's disease	0.00127	0.0167	CcSEcCtD
Drospirenone—Affect lability—Donepezil—Alzheimer's disease	0.00126	0.0166	CcSEcCtD
Drospirenone—Mood swings—Donepezil—Alzheimer's disease	0.00121	0.016	CcSEcCtD
Drospirenone—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00118	0.0156	CcSEcCtD
Drospirenone—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.00116	0.0153	CcSEcCtD
Drospirenone—Haemoglobin—Galantamine—Alzheimer's disease	0.00115	0.0151	CcSEcCtD
Drospirenone—Affect lability—Memantine—Alzheimer's disease	0.00114	0.015	CcSEcCtD
Drospirenone—Haemorrhage—Galantamine—Alzheimer's disease	0.00114	0.015	CcSEcCtD
Drospirenone—Migraine—Rivastigmine—Alzheimer's disease	0.00112	0.0147	CcSEcCtD
Drospirenone—Affect lability—Rivastigmine—Alzheimer's disease	0.00112	0.0147	CcSEcCtD
Drospirenone—NR3C2—forebrain—Alzheimer's disease	0.0011	0.064	CbGeAlD
Drospirenone—Mood swings—Memantine—Alzheimer's disease	0.0011	0.0145	CcSEcCtD
Drospirenone—Mood swings—Rivastigmine—Alzheimer's disease	0.00108	0.0142	CcSEcCtD
Drospirenone—Angiopathy—Galantamine—Alzheimer's disease	0.00103	0.0136	CcSEcCtD
Drospirenone—Breast disorder—Rivastigmine—Alzheimer's disease	0.00103	0.0135	CcSEcCtD
Drospirenone—NR3C2—telencephalon—Alzheimer's disease	0.00101	0.0589	CbGeAlD
Drospirenone—Mental disorder—Galantamine—Alzheimer's disease	0.000999	0.0132	CcSEcCtD
Drospirenone—Depression—Donepezil—Alzheimer's disease	0.000982	0.0129	CcSEcCtD
Drospirenone—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000971	0.0128	CcSEcCtD
Drospirenone—PTGS2—blood vessel—Alzheimer's disease	0.000969	0.0563	CbGeAlD
Drospirenone—Myocardial infarction—Donepezil—Alzheimer's disease	0.000965	0.0127	CcSEcCtD
Drospirenone—Depression—Memantine—Alzheimer's disease	0.000892	0.0117	CcSEcCtD
Drospirenone—Haemoglobin—Donepezil—Alzheimer's disease	0.000888	0.0117	CcSEcCtD
Drospirenone—Haemorrhage—Donepezil—Alzheimer's disease	0.000884	0.0116	CcSEcCtD
Drospirenone—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000881	0.0116	CcSEcCtD
Drospirenone—Myocardial infarction—Memantine—Alzheimer's disease	0.000876	0.0115	CcSEcCtD
Drospirenone—Depression—Rivastigmine—Alzheimer's disease	0.000872	0.0115	CcSEcCtD
Drospirenone—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000862	0.0114	CcSEcCtD
Drospirenone—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000857	0.0113	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00084	0.0111	CcSEcCtD
Drospirenone—AR—forebrain—Alzheimer's disease	0.000816	0.0474	CbGeAlD
Drospirenone—Haemoglobin—Memantine—Alzheimer's disease	0.000807	0.0106	CcSEcCtD
Drospirenone—Haemorrhage—Memantine—Alzheimer's disease	0.000803	0.0106	CcSEcCtD
Drospirenone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000795	0.0105	CcSEcCtD
Drospirenone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000789	0.0104	CcSEcCtD
Drospirenone—Skin disorder—Galantamine—Alzheimer's disease	0.000787	0.0104	CcSEcCtD
Drospirenone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000785	0.0103	CcSEcCtD
Drospirenone—Mental disorder—Donepezil—Alzheimer's disease	0.000774	0.0102	CcSEcCtD
Drospirenone—Erythema multiforme—Memantine—Alzheimer's disease	0.000759	0.01	CcSEcCtD
Drospirenone—AR—telencephalon—Alzheimer's disease	0.00075	0.0436	CbGeAlD
Drospirenone—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000742	0.00978	CcSEcCtD
Drospirenone—Angiopathy—Memantine—Alzheimer's disease	0.000728	0.0096	CcSEcCtD
Drospirenone—Angiopathy—Rivastigmine—Alzheimer's disease	0.000712	0.00939	CcSEcCtD
Drospirenone—Mental disorder—Memantine—Alzheimer's disease	0.000703	0.00927	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.0007	0.00922	CcSEcCtD
Drospirenone—Mental disorder—Rivastigmine—Alzheimer's disease	0.000688	0.00906	CcSEcCtD
Drospirenone—BCHE—forebrain—Alzheimer's disease	0.000664	0.0386	CbGeAlD
Drospirenone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000616	0.00812	CcSEcCtD
Drospirenone—BCHE—telencephalon—Alzheimer's disease	0.00061	0.0355	CbGeAlD
Drospirenone—NR3C2—nervous system—Alzheimer's disease	0.000598	0.0348	CbGeAlD
Drospirenone—PTGS2—embryo—Alzheimer's disease	0.000578	0.0336	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000578	0.00762	CcSEcCtD
Drospirenone—NR3C2—central nervous system—Alzheimer's disease	0.000576	0.0335	CbGeAlD
Drospirenone—NR3C2—cerebellum—Alzheimer's disease	0.000563	0.0327	CbGeAlD
Drospirenone—Nervous system disorder—Memantine—Alzheimer's disease	0.000559	0.00737	CcSEcCtD
Drospirenone—PGR—nervous system—Alzheimer's disease	0.000556	0.0323	CbGeAlD
Drospirenone—Skin disorder—Memantine—Alzheimer's disease	0.000554	0.0073	CcSEcCtD
Drospirenone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000547	0.00721	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000542	0.00714	CcSEcCtD
Drospirenone—Skin disorder—Rivastigmine—Alzheimer's disease	0.000542	0.00714	CcSEcCtD
Drospirenone—PGR—central nervous system—Alzheimer's disease	0.000535	0.0311	CbGeAlD
Drospirenone—PGR—cerebellum—Alzheimer's disease	0.000523	0.0304	CbGeAlD
Drospirenone—PTGS2—forebrain—Alzheimer's disease	0.000511	0.0297	CbGeAlD
Drospirenone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000492	0.00649	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000482	0.00635	CcSEcCtD
Drospirenone—Nausea—Galantamine—Alzheimer's disease	0.000481	0.00634	CcSEcCtD
Drospirenone—PTGS2—telencephalon—Alzheimer's disease	0.00047	0.0273	CbGeAlD
Drospirenone—NR3C2—brain—Alzheimer's disease	0.000457	0.0266	CbGeAlD
Drospirenone—AR—nervous system—Alzheimer's disease	0.000443	0.0257	CbGeAlD
Drospirenone—AR—central nervous system—Alzheimer's disease	0.000426	0.0248	CbGeAlD
Drospirenone—PGR—brain—Alzheimer's disease	0.000425	0.0247	CbGeAlD
Drospirenone—Nausea—Donepezil—Alzheimer's disease	0.000373	0.00492	CcSEcCtD
Drospirenone—BCHE—nervous system—Alzheimer's disease	0.00036	0.0209	CbGeAlD
Drospirenone—BCHE—central nervous system—Alzheimer's disease	0.000347	0.0202	CbGeAlD
Drospirenone—BCHE—cerebellum—Alzheimer's disease	0.000339	0.0197	CbGeAlD
Drospirenone—Nausea—Memantine—Alzheimer's disease	0.000339	0.00446	CcSEcCtD
Drospirenone—AR—brain—Alzheimer's disease	0.000338	0.0197	CbGeAlD
Drospirenone—Nausea—Rivastigmine—Alzheimer's disease	0.000331	0.00437	CcSEcCtD
Drospirenone—PTGS2—nervous system—Alzheimer's disease	0.000278	0.0161	CbGeAlD
Drospirenone—BCHE—brain—Alzheimer's disease	0.000275	0.016	CbGeAlD
Drospirenone—PTGS2—central nervous system—Alzheimer's disease	0.000267	0.0155	CbGeAlD
Drospirenone—PTGS2—cerebellum—Alzheimer's disease	0.000261	0.0152	CbGeAlD
Drospirenone—PTGS2—brain—Alzheimer's disease	0.000212	0.0123	CbGeAlD
Drospirenone—PGR—Signaling Pathways—PYY—Alzheimer's disease	4.9e-05	0.000935	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	4.89e-05	0.000934	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	4.82e-05	0.00092	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—PRKCG—Alzheimer's disease	4.78e-05	0.000913	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCL2—Alzheimer's disease	4.75e-05	0.000906	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ATP5A1—Alzheimer's disease	4.66e-05	0.00089	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—HSPD1—Alzheimer's disease	4.66e-05	0.00089	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	4.62e-05	0.000882	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	4.58e-05	0.000874	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	4.57e-05	0.000873	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL1B—Alzheimer's disease	4.56e-05	0.000869	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	4.55e-05	0.000869	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PLD3—Alzheimer's disease	4.45e-05	0.000849	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.45e-05	0.000849	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.4e-05	0.000839	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	4.35e-05	0.000831	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HSD17B10—Alzheimer's disease	4.27e-05	0.000814	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	4.25e-05	0.000811	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDK5—Alzheimer's disease	4.25e-05	0.000811	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	4.24e-05	0.00081	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	4.24e-05	0.000809	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—DHCR24—Alzheimer's disease	4.24e-05	0.000808	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.17e-05	0.000796	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—ESR1—Alzheimer's disease	4.16e-05	0.000794	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—CALM1—Alzheimer's disease	4.14e-05	0.00079	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP46A1—Alzheimer's disease	4.11e-05	0.000784	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—EIF2S1—Alzheimer's disease	4.1e-05	0.000783	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR6—Alzheimer's disease	4.09e-05	0.00078	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GAPDHS—Alzheimer's disease	4.04e-05	0.000772	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	4.02e-05	0.000768	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ND1—Alzheimer's disease	3.97e-05	0.000757	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.95e-05	0.000754	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	3.94e-05	0.000752	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—IL6—Alzheimer's disease	3.93e-05	0.00075	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.91e-05	0.000746	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ACHE—Alzheimer's disease	3.85e-05	0.000734	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—PPARG—Alzheimer's disease	3.8e-05	0.000725	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PSENEN—Alzheimer's disease	3.71e-05	0.000709	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	3.67e-05	0.0007	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APH1A—Alzheimer's disease	3.66e-05	0.000699	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CTSD—Alzheimer's disease	3.64e-05	0.000695	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	3.64e-05	0.000694	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—AKT1—Alzheimer's disease	3.63e-05	0.000692	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.61e-05	0.000689	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL1B—Alzheimer's disease	3.6e-05	0.000687	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CA4—Alzheimer's disease	3.6e-05	0.000687	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CASP3—Alzheimer's disease	3.59e-05	0.000686	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NCSTN—Alzheimer's disease	3.57e-05	0.00068	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.55e-05	0.000677	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—CREB1—Alzheimer's disease	3.54e-05	0.000676	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.52e-05	0.000672	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TTR—Alzheimer's disease	3.51e-05	0.000669	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LRP1—Alzheimer's disease	3.48e-05	0.000663	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—GSK3A—Alzheimer's disease	3.41e-05	0.00065	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GFAP—Alzheimer's disease	3.4e-05	0.000648	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GAL—Alzheimer's disease	3.4e-05	0.000648	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GAPDHS—Alzheimer's disease	3.39e-05	0.000646	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.31e-05	0.000632	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—Alzheimer's disease	3.31e-05	0.000631	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	3.3e-05	0.00063	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	3.29e-05	0.000628	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—ESR1—Alzheimer's disease	3.29e-05	0.000628	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ACE—Alzheimer's disease	3.24e-05	0.000619	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ATP5A1—Alzheimer's disease	3.21e-05	0.000613	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NOTCH1—Alzheimer's disease	3.18e-05	0.000607	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	3.18e-05	0.000606	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	3.17e-05	0.000605	CbGpPWpGaD
Drospirenone—AR—Gene Expression—EIF2S1—Alzheimer's disease	3.13e-05	0.000596	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.09e-05	0.00059	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	3.06e-05	0.000585	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLD3—Alzheimer's disease	3.06e-05	0.000584	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.06e-05	0.000584	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.06e-05	0.000583	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.03e-05	0.000578	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PPARG—Alzheimer's disease	3e-05	0.000573	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—A2M—Alzheimer's disease	2.99e-05	0.000571	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HSD17B10—Alzheimer's disease	2.94e-05	0.00056	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.93e-05	0.00056	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PSEN2—Alzheimer's disease	2.9e-05	0.000553	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	2.89e-05	0.000552	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.87e-05	0.000548	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP46A1—Alzheimer's disease	2.83e-05	0.000539	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TGFB1—Alzheimer's disease	2.8e-05	0.000534	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.78e-05	0.000531	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	2.78e-05	0.00053	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	2.77e-05	0.000529	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ND1—Alzheimer's disease	2.73e-05	0.000521	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.73e-05	0.00052	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.67e-05	0.000509	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NPY—Alzheimer's disease	2.67e-05	0.000509	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	2.67e-05	0.000509	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IAPP—Alzheimer's disease	2.65e-05	0.000506	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	2.61e-05	0.000499	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SNCA—Alzheimer's disease	2.61e-05	0.000497	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—IGF2—Alzheimer's disease	2.59e-05	0.000495	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CRH—Alzheimer's disease	2.57e-05	0.000491	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CHAT—Alzheimer's disease	2.56e-05	0.000488	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TPI1—Alzheimer's disease	2.56e-05	0.000488	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MAOB—Alzheimer's disease	2.45e-05	0.000468	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.45e-05	0.000467	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.44e-05	0.000466	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NPS—Alzheimer's disease	2.44e-05	0.000466	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PPP3CA—Alzheimer's disease	2.43e-05	0.000463	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTK2B—Alzheimer's disease	2.39e-05	0.000457	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GAPDH—Alzheimer's disease	2.36e-05	0.00045	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.33e-05	0.000445	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GAB2—Alzheimer's disease	2.33e-05	0.000444	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NTRK2—Alzheimer's disease	2.33e-05	0.000444	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SST—Alzheimer's disease	2.33e-05	0.000444	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PSENEN—Alzheimer's disease	2.32e-05	0.000443	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.31e-05	0.000441	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GSK3A—Alzheimer's disease	2.31e-05	0.00044	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	2.3e-05	0.00044	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.3e-05	0.000439	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APH1A—Alzheimer's disease	2.29e-05	0.000437	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—A2M—Alzheimer's disease	2.28e-05	0.000435	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APP—Alzheimer's disease	2.27e-05	0.000433	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.25e-05	0.000429	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NCSTN—Alzheimer's disease	2.23e-05	0.000426	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LRP1—Alzheimer's disease	2.18e-05	0.000415	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PLCB1—Alzheimer's disease	2.14e-05	0.000408	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	2.11e-05	0.000403	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.1e-05	0.000401	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TPI1—Alzheimer's disease	2.1e-05	0.000401	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.07e-05	0.000396	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.03e-05	0.000388	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—LEP—Alzheimer's disease	2.02e-05	0.000385	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ESR1—Alzheimer's disease	2e-05	0.000382	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NGFR—Alzheimer's disease	2e-05	0.000381	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ACHE—Alzheimer's disease	1.98e-05	0.000378	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EIF2AK2—Alzheimer's disease	1.98e-05	0.000377	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—INPP5D—Alzheimer's disease	1.96e-05	0.000374	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADAM10—Alzheimer's disease	1.95e-05	0.000372	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GAPDH—Alzheimer's disease	1.94e-05	0.00037	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH1—Alzheimer's disease	1.94e-05	0.00037	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.92e-05	0.000365	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.9e-05	0.000363	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—F2—Alzheimer's disease	1.9e-05	0.000363	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS1—Alzheimer's disease	1.86e-05	0.000354	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ENO1—Alzheimer's disease	1.86e-05	0.000354	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—S100B—Alzheimer's disease	1.84e-05	0.000352	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARG—Alzheimer's disease	1.83e-05	0.000349	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP2D6—Alzheimer's disease	1.82e-05	0.000348	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PSEN2—Alzheimer's disease	1.81e-05	0.000346	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.78e-05	0.000339	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CST3—Alzheimer's disease	1.77e-05	0.000338	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TPI1—Alzheimer's disease	1.76e-05	0.000336	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CHAT—Alzheimer's disease	1.76e-05	0.000336	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF2—Alzheimer's disease	1.76e-05	0.000335	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—INS—Alzheimer's disease	1.72e-05	0.000328	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF1R—Alzheimer's disease	1.7e-05	0.000324	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	1.69e-05	0.000323	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MAOB—Alzheimer's disease	1.69e-05	0.000322	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	1.67e-05	0.000318	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IAPP—Alzheimer's disease	1.66e-05	0.000316	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PLCB1—Alzheimer's disease	1.63e-05	0.000311	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LPL—Alzheimer's disease	1.63e-05	0.000311	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GAPDH—Alzheimer's disease	1.62e-05	0.00031	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MEF2C—Alzheimer's disease	1.61e-05	0.000308	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.61e-05	0.000306	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.6e-05	0.000305	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.59e-05	0.000303	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCG—Alzheimer's disease	1.58e-05	0.000302	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCA1—Alzheimer's disease	1.58e-05	0.000301	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—A2M—Alzheimer's disease	1.57e-05	0.000299	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.57e-05	0.000299	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NGF—Alzheimer's disease	1.54e-05	0.000294	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ESR1—Alzheimer's disease	1.53e-05	0.000291	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ENO1—Alzheimer's disease	1.53e-05	0.000291	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PPP3CA—Alzheimer's disease	1.52e-05	0.00029	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR5—Alzheimer's disease	1.5e-05	0.000286	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH1—Alzheimer's disease	1.48e-05	0.000282	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR2A—Alzheimer's disease	1.47e-05	0.00028	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GAB2—Alzheimer's disease	1.46e-05	0.000278	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GSK3A—Alzheimer's disease	1.44e-05	0.000275	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APP—Alzheimer's disease	1.42e-05	0.000271	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.4e-05	0.000267	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—Alzheimer's disease	1.39e-05	0.000266	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CALM1—Alzheimer's disease	1.37e-05	0.000261	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LEP—Alzheimer's disease	1.36e-05	0.00026	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOE—Alzheimer's disease	1.36e-05	0.00026	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ACHE—Alzheimer's disease	1.36e-05	0.00026	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	1.36e-05	0.00026	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HMOX1—Alzheimer's disease	1.35e-05	0.000259	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CAV1—Alzheimer's disease	1.35e-05	0.000258	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—INPP5D—Alzheimer's disease	1.35e-05	0.000257	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.32e-05	0.000253	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ESR1—Alzheimer's disease	1.3e-05	0.000249	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—F2—Alzheimer's disease	1.29e-05	0.000246	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTGS1—Alzheimer's disease	1.28e-05	0.000244	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ENO1—Alzheimer's disease	1.28e-05	0.000244	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH1—Alzheimer's disease	1.26e-05	0.00024	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	1.25e-05	0.000239	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—LPL—Alzheimer's disease	1.24e-05	0.000236	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ADAM10—Alzheimer's disease	1.22e-05	0.000233	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—BCHE—Alzheimer's disease	1.19e-05	0.000227	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—Alzheimer's disease	1.19e-05	0.000226	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GSK3B—Alzheimer's disease	1.18e-05	0.000225	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CREB1—Alzheimer's disease	1.17e-05	0.000224	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—INS—Alzheimer's disease	1.17e-05	0.000222	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL2—Alzheimer's disease	1.15e-05	0.000219	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF1—Alzheimer's disease	1.13e-05	0.000215	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLCB1—Alzheimer's disease	1.12e-05	0.000214	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MTHFR—Alzheimer's disease	1.12e-05	0.000213	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCA1—Alzheimer's disease	1.09e-05	0.000207	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CALM1—Alzheimer's disease	1.04e-05	0.000199	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOE—Alzheimer's disease	1.04e-05	0.000198	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CAV1—Alzheimer's disease	1.03e-05	0.000196	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOS3—Alzheimer's disease	1.02e-05	0.000195	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LPL—Alzheimer's disease	1.02e-05	0.000194	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKCG—Alzheimer's disease	9.9e-06	0.000189	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CCR5—Alzheimer's disease	9.38e-06	0.000179	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	9.37e-06	0.000179	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMOX1—Alzheimer's disease	9.32e-06	0.000178	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTHFR—Alzheimer's disease	9.17e-06	0.000175	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—Alzheimer's disease	9.05e-06	0.000173	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—INS—Alzheimer's disease	8.87e-06	0.000169	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CASP3—Alzheimer's disease	8.68e-06	0.000166	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALM1—Alzheimer's disease	8.57e-06	0.000163	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOE—Alzheimer's disease	8.54e-06	0.000163	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LPL—Alzheimer's disease	8.53e-06	0.000163	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CAV1—Alzheimer's disease	8.46e-06	0.000161	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK8—Alzheimer's disease	7.98e-06	0.000152	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS2—Alzheimer's disease	7.95e-06	0.000152	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOTCH1—Alzheimer's disease	7.88e-06	0.00015	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NOS3—Alzheimer's disease	7.78e-06	0.000148	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTHFR—Alzheimer's disease	7.68e-06	0.000147	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GSK3B—Alzheimer's disease	7.39e-06	0.000141	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—Alzheimer's disease	7.37e-06	0.000141	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CREB1—Alzheimer's disease	7.33e-06	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Disease—INS—Alzheimer's disease	7.29e-06	0.000139	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—Alzheimer's disease	7.23e-06	0.000138	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CALM1—Alzheimer's disease	7.17e-06	0.000137	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOE—Alzheimer's disease	7.15e-06	0.000136	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—Alzheimer's disease	7.12e-06	0.000136	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CAV1—Alzheimer's disease	7.08e-06	0.000135	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—Alzheimer's disease	6.76e-06	0.000129	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS3—Alzheimer's disease	6.39e-06	0.000122	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—Alzheimer's disease	6.23e-06	0.000119	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—INS—Alzheimer's disease	6.11e-06	0.000117	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—Alzheimer's disease	5.56e-06	0.000106	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—Alzheimer's disease	5.51e-06	0.000105	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NOS3—Alzheimer's disease	5.36e-06	0.000102	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—Alzheimer's disease	5.09e-06	9.72e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—Alzheimer's disease	4.7e-06	8.97e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—Alzheimer's disease	4.23e-06	8.07e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—Alzheimer's disease	3.58e-06	6.83e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—Alzheimer's disease	3.19e-06	6.08e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—Alzheimer's disease	2.94e-06	5.61e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—Alzheimer's disease	2.46e-06	4.7e-05	CbGpPWpGaD
